Tumorigenesis Suppressor Pdcd4 Down-Regulates Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 Expression to Suppress Colon Carcinoma Cell Invasion
Open accessAbstract
Programmed cell death 4 (Pdcd4) suppresses neoplastic transformation by inhibiting the activation of c-Jun and consequently AP-1-dependent transcription. We report that Pdcd4 blocks c-Jun activation by inhibiting the expression of mitogen-activated protein kinase kinase kinase kinase 1 (MAP4K1)/hematopoietic progenitor kinase 1, a kinase upstream of Jun N-terminal kinase (JNK). cDNA microarray analysis of Pdcd4-overexpressing RKO human colon carcinoma cells revealed MAP4K1 as the sole target of Pdcd4 on the JNK activation pathway. Cotransfection of a MAP4K1 promoter-reporter with Pdcd4 demonstrated inhibition of transcription from the MAP4K1 promoter. Ectopic expression of Pdcd4 in metastatic RKO cells suppressed invasion. MAP4K1 activity is functionally significant in invasion, as overexpression of a dominant negative MAP4K1 (dnMAP4K1) mutant in RKO cells inhibited not only c-Jun activation but also invasion. Overexpression of a MAP4K1 cDNA in Pdcd4-transfected cells rescued the kinase activity of JNK. Thus, Pdcd4 suppresses tumor progression in human colon carcinoma cells by the novel mechanism of down-regulating MAP4K1 transcription, with consequent inhibition of c-Jun activation and AP-1-dependent transcription.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PDCD4 suppresses expression of the upstream kinase MAP4K1 in RKO human colon carcinoma cells.
“PDCD4 was shown to inhibit the activation of c-Jun by suppressing the JNK-activation in avian QT6 cells [34] and to suppress the expression of the upstream kinase MAP4K1 in RKO human colon carcinoma cells [33].”
From Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions (2019) · cites this paper as [33]
Cites
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232 · see citing works
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217 · see citing works
The Activity of Collagenase-1 Is Required for Keratinocyte Migration on a Type I Collagen Matrix
Pilcher, B. K., Dumin, J. A., Sudbeck, B. D., Krane, S. M., Welgus, H. G., & Parks, W. C. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.6.1445 · Cited by 613 · see citing works
Curran, S., & Murray, G. I. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00156-8 · Cited by 537 · see citing works
The AP-1 site and MMP gene regulation: What is all the fuss about?
Benbow, U., & Brinckerhoff, C. (1997) · Matrix Biology · doi:10.1016/s0945-053x(97)90026-3 · Cited by 521 · see citing works
Yang, H.-S., Jansen, A. P., Komar, A. A., Zheng, X., Merrick, W. C., Costes, S., Lockett, S. J., Sonenberg, N., & Colburn, N. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.26-37.2003 · Cited by 494 · see citing works
Self-citationA Signaling Pathway to Translational Control
Brown, E. J., & Schreiber, S. L. (1996) · Cell · doi:10.1016/s0092-8674(00)80125-7 · Cited by 364 · see citing works
eIF4E expression in tumors: its possible role in progression of malignancies
Benedetti, A. D., & Harris, A. L. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00132-0 · Cited by 326 · see citing works
Robinson, M. J., Stippec, S. A., Goldsmith, E. J., White, M. A., & Cobb, M. H. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00485-x · Cited by 311 · see citing works
The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis
Yuspa, S. H. (1998) · Journal of Dermatological Science · doi:10.1016/s0923-1811(97)00071-6 · Cited by 301 · see citing works
Marconcini, L., Marchiò, S., Morbidelli, L., Cartocci, E., Albini, A., Ziche, M., Bussolino, F., & Oliviero, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9671 · Cited by 276 · see citing works
Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis
Chen, Y., Knösel, T., Kristiansen, G., Pietas, A., Garber, M. E., Matsuhashi, S., Ozaki, I., & Petersen, I. (2003) · The Journal of Pathology · doi:10.1002/path.1378 · Cited by 265 · see citing works
Hu, M. C. ‐., Qiu, W., Wang, X., Meyer, C. F., & Tan, T. (1996) · Genes & Development · doi:10.1101/gad.10.18.2251 · Cited by 255 · see citing works
Self-citationDifferentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation
Cmarik, J. L., Min, H., Hegamyer, G., Zhan, S., Kulesz-Martin, M., Yoshinaga, H., Matsuhashi, S., & Colburn, N. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14037 · Cited by 254 · see citing works
Self-citationHPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway.
Kiefer, F., Tibbles, L. A., Anafi, M., Janssen, A., Zanke, B. W., Lassam, N. J., Pawson, T. J., Woodgett, J. R., & Iscove, N. N. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01093.x · Cited by 242 · see citing works
Reeves, R., Edberg, D. D., & Li, Y. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.2.575-594.2001 · Cited by 242 · see citing works
Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death
Shibahara, K., Asano, M., Ishida, Y., Aoki, T., Koike, T., & Honjo, T. (1995) · Gene · doi:10.1016/0378-1119(95)00607-9 · Cited by 223 · see citing works
Epidermal Expression of the Translation Inhibitor Programmed Cell Death 4 Suppresses Tumorigenesis
Jansen, A. P., Camalier, C. E., & Colburn, N. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2119 · Cited by 212 · see citing works
Self-citationYang, H.-S., Cho, M.-H., Zakowicz, H., Hegamyer, G., Sonenberg, N., & Colburn, N. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.9.3894-3906.2004 · Cited by 199 · see citing works
Self-citationCrawford, H. C., & Matrisian, L. M. (2017) · Enzyme and Protein · doi:10.1159/000468614 · Cited by 194 · see citing works
Bramhall, S. R., Neoptolemos, J. P., Stamp, G., & Lemoine, N. R. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199707)182:3 · Cited by 192 · see citing works
Yang, H.-S., Jansen, A. P., Nair, R., Shibahara, K., Verma, A. K., Cmarik, J. L., & Colburn, N. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204137 · Cited by 185 · see citing works
Self-citationAP-1-Mediated Invasion Requires Increased Expression of the Hyaluronan Receptor CD44
Lamb, R. F., Hennigan, R. F., Turnbull, K., Katsanakis, K. D., MacKenzie, E. D., Birnie, G. D., & Ozanne, B. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.963 · Cited by 173 · see citing works
Chauhan, D., Auclair, D., Robinson, E. K., Hideshima, T., Li, G., Podar, K., Gupta, D., Richardson, P. G. G., Schlossman, R. L., Krett, N. L., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205205 · Cited by 165 · see citing works
Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation
Yang, H.-S., Knies, J. L., Stark, C., & Colburn, N. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206433 · Cited by 160 · see citing works
Self-citationAfonja, O., Juste, D., Das, S., Matsuhashi, S., & Samuels, H. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207983 · Cited by 154 · see citing works
HPK1 Is Activated by Lymphocyte Antigen Receptors and Negatively Regulates AP-1
Liou, J., Kiefer, F., Dang, A., Hashimoto, A., Cobb, M. H., Kurosaki, T., & Weiss, A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80192-2 · Cited by 140 · see citing works
Shin, M., Yan, C., & Boyd, D. D. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00195-7 · Cited by 137 · see citing works
Bitomsky, N., Böhm, M., & Klempnauer, K.-H. (2004) · Oncogene · doi:10.1038/sj.onc.1208064 · Cited by 134 · see citing works
Jansen, A. P., Camalier, C. E., Stark, C., & Colburn, N. H. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.103.3.2 · Cited by 132 · see citing works
Self-citationSauer, K., Liou, J., Singh, S. B., Yablonski, D., Weiss, A., & Perlmutter, R. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106811200 · Cited by 129 · see citing works
Transcriptional regulation of cell invasion
Ozanne, B. W., McGarry, L., Spence, H. J., Johnston, I., Winnie, J. N., Meagher, L., & Stapleton, G. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00175-1 · Cited by 123 · see citing works
Fos-transformation activates genes associated with invasion.
Hennigan, R. F., Hawker, K., & Ozanne, B. W. (1994) · PubMed · Cited by 120 · see citing works
Rogalla, P., Drechsler, K., Kazmierczak, B., Rippe, V., Bonk, U., & BULLERDIEK, J. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199707)19:3 · Cited by 109 · see citing works
Self-citationAzzoni, L., Zatsepina, O., Abebe, B., Bennett, I. M., Kanakaraj, P., & Perussia, B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3493 · Cited by 105 · see citing works
Cooper, S. J., MacGowan, J., Ranger‐Moore, J., Young, M. R., Colburn, N. H., & Bowden, G. T. (2003) · PubMed · Cited by 100 · see citing works
Self-citationDUG is a novel homologue of translation initiation factor 4G that binds eIF4A
Göke, A., Göke, R., Knolle, A., Trusheim, H., Schmidt, H., Wilmen, A., Carmody, R. J., Göke, B., & Chen, Y. H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02129-0 · Cited by 92 · see citing works
Zhang, Z., & DuBois, R. N. (2001) · Oncogene · doi:10.1038/sj.onc.1204588 · Cited by 90 · see citing works
Involvement of Hematopoietic Progenitor Kinase 1 in T Cell Receptor Signaling
Ling, P., Meyer, C. F., Redmond, L. P., Shui, J., Davis, B. K., Rich, R. R., Hu, M. C. ‐., Wange, R. L., & Tan, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101485200 · Cited by 90 · see citing works
Self-citationLing, P., Yao, Z., Meyer, C. F., Wang, X. S., Oehrl, W., Feller, S. M., & Tan, T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1359 · Cited by 83 · see citing works
Self-citationRole of Jun and Jun kinase in resistance of cancer cells to therapy
Vasilevskaya, I. A., & O'Dwyer, P. J. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00043-8 · Cited by 80 · see citing works
Zhou, G., Lee, S. C., Yao, Z., & Tan, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13133 · Cited by 79 · see citing works
Self-citationPdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II
Lankat–Buttgereit, B., Gregel, C. M., Knolle, A., Hasilík, A., Arnold, R., & Göke, R. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.058 · Cited by 75 · see citing works
Functional interactions of HPK1 with adaptor proteins
Boomer, J. S., & Tan, T. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20401 · Cited by 64 · see citing works
Self-citationZakowicz, H., Yang, H., Stark, C., Wlodawer, A., LaRonde-LeBlanc, N. A., & Colburn, N. H. (2005) · RNA · doi:10.1261/rna.7191905 · Cited by 60 · see citing works
Self-citationDhar, A., Hu, J., Reeves, R., Resar, L. M. S., & Colburn, N. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207581 · Cited by 58 · see citing works
Self-citationUp-regulation of PDCD4 in senescent human diploid fibroblasts
Kang, M.-J., Ahn, H.-S., Lee, J.-Y., Matsuhashi, S., & Park, W.-Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00264-4 · Cited by 57 · see citing works
c-Jun N-terminal kinase is involved in motility of endothelial cell
Shin, E., Kim, S.-Y., & Kim, E. (2001) · Experimental & Molecular Medicine · doi:10.1038/emm.2001.45 · Cited by 56 · see citing works
Proud, C. G. (1994) · Nature · doi:10.1038/371747a0 · Cited by 55 · see citing works
Ma, W., Xia, C., Ling, P., Qiu, M. S., Luo, Y., Tan, T., & Liu, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204224 · Cited by 55 · see citing works
Self-citationProgrammed Cell Death Protein 4 (PDCD4) Acts As a Tumor Suppressor in Neuroendocrine Tumor Cells
Göke, R., Gregel, C. M., Göke, A., Arnold, R., Schmidt, H., & Lankat–Buttgereit, B. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.024 · Cited by 49 · see citing works
Molecular Cloning of the Genes Suppressed in RVC Lymphoma Cells by Topoisomerase Inhibitors
Onishi, Y., & Kizaki, H. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1609 · Cited by 34 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882 · see citing works
Self-citationMicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., & Mo, Y.-Y. (2008) · Cell Research · doi:10.1038/cr.2008.24 · Cited by 1,051 · see citing works
miR‐21: a small multi‐faceted RNA
Krichevsky, A. M., & Gabriely, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00556.x · Cited by 987 · see citing works
Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer
Mudduluru, G., George-William, J. N., Muppala, S., Asangani, I. A., Kumarswamy, R., Nelson, L. D., & Allgayer, H. (2011) · Bioscience Reports · doi:10.1042/bsr20100065 · Cited by 332 · see citing works
Chen, Y., Yang, F., Fang, E., Xiao, W., Mei, H., Li, H., Li, D., Song, H., Wang, J., Mei, H., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0220-6 · Cited by 322 · see citing works
The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation
Lankat–Buttgereit, B., & Göke, R. (2009) · Biology of the Cell · doi:10.1042/bc20080191 · Cited by 307 · see citing works
An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation
Talotta, F., Cimmino, A., Matarazzo, M. R., Casalino, L., De Vita, G., D'Esposito, M., Di Lauro, R., & Verde, P. (2009) · Oncogene · doi:10.1038/onc.2008.370 · Cited by 242 · see citing works
Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis
Ma, X., Kumar, M., Choudhury, S. N., Buscaglia, L. E. B., Barker, J. R., Kanakamedala, K., Liu, M., & Li, Y. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103735108 · Cited by 214 · see citing works
JNK-Induced Apoptosis, Compensatory Growth, and Cancer Stem Cells
Chen, F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1982 · Cited by 205 · see citing works
The microRNA-21−PDCD4 axis prevents type 1 diabetes by blocking pancreatic β cell death
Ruan, Q., Wang, T., Kameswaran, V., Wei, Q., Johnson, D. S., Matschinsky, F. M., Shi, W., & Chen, Y. H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101450108 · Cited by 201 · see citing works
Mudduluru, G., Medved, F., Grobholz, R., Jost, C., Gruber, A., Leupold, J. H., Post, S., Jansen, A., Colburn, N. H., & Allgayer, H. (2007) · Cancer · doi:10.1002/cncr.22983 · Cited by 196 · see citing works
Self-citationA Network Model of a Cooperative Genetic Landscape in Brain Tumors
Bredel, M., Scholtens, D. M., Harsh, G. R., Bredel, C., Chandler, J. P., Renfrow, J. J., Yadav, A. K., Vogel, H. S., Scheck, A. C., Tibshirani, R. J., et al. (2009) · JAMA · doi:10.1001/jama.2009.997 · Cited by 190 · see citing works
Li, B., Ren, S., Li, X., Wang, Y., Garfield, D. H., Zhou, S., Chen, X., Su, C., Chen, M., Kuang, P., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.11.003 · Cited by 176 · see citing works
Modelska, A., Turro, E., Russell, R. B., Beaton, J., Sbarrato, T., Spriggs, K. A., Miller, J. L., Gräf, S., Provenzano, E., Blows, F. M., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.542 · Cited by 174 · see citing works
Fang, W., Li, X., Jiang, Q., Liu, Z., Yang, H., Wang, S., Xie, S., Liu, Q., Liu, T., Huang, J., et al. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-32 · Cited by 170 · see citing works
Self-citationLeupold, J. H., Yang, H.-S., Colburn, N. H., Asangani, I., Post, S., & Allgayer, H. (2007) · Oncogene · doi:10.1038/sj.onc.1210234 · Cited by 163 · see citing works
Self-citationExosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer
Ning, T., Li, J., He, Y., Zhang, H., Wang, X., Deng, T., Liu, R., Li, H., Bai, M., Fan, Q., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.028 · Cited by 156 · see citing works
Translation Inhibitor Pdcd4 Is Targeted for Degradation during Tumor Promotion
Schmid, T., Jansen, A. P., Baker, A. R., Hegamyer, G., Hagan, J. P., & Colburn, N. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1719 · Cited by 151 · see citing works
Self-citationLiu, X., Zhang, Z., Sun, L. J., Chai, N., Tang, S., Jin, J., Hu, H., Nie, Y., Wang, X., Wu, K., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr213 · Cited by 148 · see citing works
Wang, Q., Sun, Z., & Yang, H. (2007) · Oncogene · doi:10.1038/sj.onc.1210793 · Cited by 147 · see citing works
Self-citationShi, G., Ye, D., Yao, X.-D., Zhang, S.-L., Dai, B., Zhang, H., Shen, Y.-J., Zhu, Y., Zhu, Y., Xiao, W.-J., et al. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.48 · Cited by 147 · see citing works
Wang, Z. (2012) · Oncology Reports · doi:10.3892/or.2012.1682 · Cited by 146 · see citing works
Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions
Matsuhashi, S., Manirujjaman, M., Hamajima, H., & Ozaki, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092304 · Cited by 143 · see citing works
Reis, P. P., Tomenson, M., Cervigne, N. K., Machado, J., Jurišica, I., Pintilie, M., Sukhai, M. A., Perez‐Ordoñez, B., Grenman, R. A., Gilbert, R. W., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-238 · Cited by 142 · see citing works
Shiota, M., Izumi, H., Tanimoto, A., Takahashi, M., Miyamoto, N., Kashiwagi, E., Kidani, A., Hirano, G., Masubuchi, D., Fukunaka, Y., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2334 · Cited by 134 · see citing works
DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation
Cui, H., Wang, Q., Lei, Z., Feng, M., Zhao, Z., Wang, Y., & Wei, G. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1358-x · Cited by 135 · see citing works
Self-citationWang, Y., Guo, R., Guo, R., Wei, S., & Yin, L. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24488 · Cited by 128 · see citing works
Park, Y. M., Hwang, S. J., Masuda, K., Choi, K.-M., Jeong, M., Nam, D., Gorospe, M., & Kim, H. H. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00443-12 · Cited by 125 · see citing works
Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer
Mori (2010) · International Journal of Oncology · doi:10.3892/ijo_00000590 · Cited by 124 · see citing works
Pdcd4, a colon cancer prognostic that is regulated by a microRNA
Allgayer, H. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.09.001 · Cited by 123 · see citing works
Kim, C., Hu, B., Jadhav, R. R., Jin, J., Zhang, H., Cavanagh, M., Akondy, R. S., Ahmed, R., Weyand, C. M., & Goronzy, J. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.074 · Cited by 123 · see citing works
The role of Pdcd4 in tumour suppression and protein translation
Wang, Q., & Yang, H. (2018) · Biology of the Cell · doi:10.1111/boc.201800014 · Cited by 113 · see citing works
Self-citationZhou, C., Li, X., Sun, H., Zhang, B., Han, Y., Jiang, Y., Zhuang, Q., Fang, J. S., & Wu, G. (2012) · IUBMB Life · doi:10.1002/iub.1066 · Cited by 104 · see citing works
Frequent loss of PDCD4 expression in human glioma: Possible role in the tumorigenesis of glioma
Gao, F., Zhang, P., Zhou, C., Li, J., Wang, Q., Zhu, F., Ma, C., Sun, W., & Zhang, L. (2007) · Oncology Reports · doi:10.3892/or.17.1.123 · Cited by 100 · see citing works
Self-citationZhou, L., Yang, Z.-X., Song, W., Li, Q., Yang, F., Wang, D., Zhang, N., & Dou, K. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1965 · Cited by 99 · see citing works
Estrogen and Progesterone Control of Gene Expression in the Mouse Meibomian Gland
Suzuki, T., Schirra, F., Richards, S. M., Jensen, R. V., & Sullivan, D. A. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1458 · Cited by 97 · see citing works
Li, X., Xin, S., He, Z., Che, X., Wang, J., Xiao, X., Chen, J., & Song, X. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000362946 · Cited by 94 · see citing works
Özpolat, B., Akar, U., Steiner, M., Zorrilla, I. R., Tírado-Gómez, M., Colburn, N. H., Danilenko, M., Kornblau, S. M., & Berestein, G. L. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0125 · Cited by 93 · see citing works
Self-citationWang, Q., Sun, Z. X., Allgayer, H., & Yang, H. S. (2010) · Oncogene · doi:10.1038/onc.2009.302 · Cited by 89 · see citing works
Self-citationTargeting mTOR for the treatment of AML. New agents and new directions
Altman, J. K., Sassano, A., & Platanias, L. C. (2011) · Oncotarget · doi:10.18632/oncotarget.290 · Cited by 86 · see citing works
Nieves-Alicea, R., Colburn, N. H., Simeone, A., & Tari, A. M. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9993-5 · Cited by 86 · see citing works
Self-citationSensing the scent of death: Modulation of microRNAs by curcumin in gastrointestinal cancers.
Ashrafizadeh, M., Zarrabi, A., Hashemipour, M., Massoud Vosough, M. P., Najafi, M., Shahinozzaman, M., Hushmandi, K., Khan, H., & Mirzaei, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105199 · Cited by 77 · see citing works
Alterations in the expression of PDCD4 in ductal carcinoma of the breast
Wen, Y., Shi, X., Chiriboga, L. A., Matsahashi, S., Yee, H. T., & Afonja, O. (2007) · Oncology Reports · doi:10.3892/or.18.6.1387 · Cited by 81 · see citing works
Targeting the eIF4A RNA helicase as an anti-neoplastic approach
Chu, J., & Pelletier, J. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.09.006 · Cited by 80 · see citing works
Dikshit, B., Irshad, K., Madan, E., Aggarwal, N., Sarkar, C., Chandra, P. S., Gupta, D. K., Chattopadhyay, P., Sinha, S., & Chosdol, K. (2012) · Oncogene · doi:10.1038/onc.2012.393 · Cited by 79 · see citing works
Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer
Wei, N., Liu, S. S., Leung, T. H., Tam, K., Liao, X. Y., Cheung, A., Chan, K. K. L., & Ngan, H. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-70 · Cited by 79 · see citing works
Yu, H., Zeng, J., Liang, X., Wang, W., Zhou, Y., Sun, Y., Liu, S., Li, W., Chen, C., & Jia, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105306 · Cited by 76 · see citing works
Structural Basis for Inhibition of Translation by the Tumor Suppressor Pdcd4
LaRonde-LeBlanc, N. A., Santhanam, A. N., Baker, A. R., Wlodawer, A., & Colburn, N. H. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00867-06 · Cited by 76 · see citing works
Self-citationsiRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression
Bitomsky, N., Wethkamp, N., Marikkannu, R., & Klempnauer, K.-H. (2008) · Oncogene · doi:10.1038/onc.2008.115 · Cited by 75 · see citing works
On the statistical assessment of classifiers using DNA microarray data
Ancona, N., Maglietta, R., Piepoli, A., D’Addabbo, A., Cotugno, R., Savino, M., Liuni, S., Carella, M., Pesole, G., & Perri, F. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-387 · Cited by 73 · see citing works
The development of small-molecule inhibitors targeting HPK1
Zhou, L., Wang, T., Zhang, K., Zhang, X., & Jiang, S. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114819 · Cited by 72 · see citing works
Chusorn, P., Namwat, N., Loilome, W., Techasen, A., Pairojkul, C., Khuntikeo, N., Dechakhamphu, A., Talabnin, C., Chan-on, W., Ong, C. K., et al. (2013) · Tumor Biology · doi:10.1007/s13277-013-0688-0 · Cited by 71 · see citing works
Hematopoietic Progenitor Kinase 1 in Tumor Immunology: A Medicinal Chemistry Perspective
Zhu, Q., Chen, N., Tian, X., Zhou, Y.-L., You, Q., & Xu, X. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00172 · Cited by 70 · see citing works
A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer
Sharma, G., Dua, P. K., & Agarwal, S. M. (2014) · Current Genomics · doi:10.2174/1389202915666140528003249 · Cited by 70 · see citing works
Carayol, N., Katsoulidis, E., Sassano, A., Altman, J. K., Druker, B. J., & Platanias, L. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707934200 · Cited by 69 · see citing works
Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma
Wang, Q., Zhu, J., Wang, Y.-W., Dai, Y., Wang, Y.-L., Wang, C., Liu, J., Baker, A., Colburn, N. H., & Yang, H.-S. (2017) · Oncogene · doi:10.1038/onc.2017.228 · Cited by 67 · see citing works
Self-citationPdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion
Santhanam, A. N., Baker, A. R., Hegamyer, G., Kirschmann, D. A., & Colburn, N. H. (2010) · Oncogene · doi:10.1038/onc.2010.158 · Cited by 67 · see citing works
Self-citationGao, F., Wang, X., Zhu, F., Wang, Q., Zhang, X., Guo, C., Zhou, C., Ma, C., Sun, W., Zhang, Y., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00497.x · Cited by 66 · see citing works
Self-citationWang, L., Jiang, Y., Song, X., Guo, C. H., Zhu, F., Wang, X., Wang, Q., Shi, Y., Wang, J., Gao, F., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.416 · Cited by 66 · see citing works
Self-citationmiR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4
Liu, Y., Ur-Rehman, U., Guo, Y., Liang, H., Cheng, R., Yang, F., Hong, Y., Zhao, C., Liu, M., Yu, M., et al. (2016) · Protein & Cell · doi:10.1007/s13238-016-0313-2 · Cited by 65 · see citing works
MicroRNA-21 suppression impedes medulloblastoma cell migration
Grunder, E., D’Ambrosio, R., Fiaschetti, G., Abela, L., Arcaro, A., Zuzak, T. J., Ohgaki, H., Lv, S., Shalaby, T., & Grotzer, M. A. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.041 · Cited by 65 · see citing works
Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA
Eto, K., Goto, S., Nakashima, W., Ura, Y., & Abe, S.-I. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.126 · Cited by 64 · see citing works
Targeting strategies on miRNA-21 and PDCD4 for glioblastoma
Wang, G., Wang, J. J., Tang, H., & To, S. S. T. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.07.001 · Cited by 63 · see citing works
Blees, J. S., Bokesch, H. R., Rübsamen, D., Schulz, K. L., Milke, L., Bajer, M. M., Gustafson, K. R., Henrich, C. J., McMahon, J. B., Colburn, N. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046567 · Cited by 63 · see citing works
Self-citationmiRNAs in breast cancer tumorigenesis (Review)
ZHANG, Z. J., & Shi, L. (2011) · Oncology Reports · doi:10.3892/or.2011.1611 · Cited by 60 · see citing works
Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
Potashkin, J. A., Santiago, J. A., Ravina, B. M., Watts, A., & Leontovich, A. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043595 · Cited by 59 · see citing works
Meng, H., Wang, K., Chen, X., Guan, X., Hu, L., Xiong, G., Li, J., & Bai, Y. (2015) · PubMed Central · Cited by 59 · see citing works
Tumour Suppressive Function and Modulation of Programmed Cell Death 4 (PDCD4) in Ovarian Cancer
Wei, N., Liu, S. S., Chan, K. K. L., & Ngan, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030311 · Cited by 58 · see citing works
Luo, F., Ji, J., Liu, Y., Xu, Y., Zheng, G., Jing, J., Wang, B., Xu, W., Shi, L., Lü, X., et al. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.11.001 · Cited by 56 · see citing works
The role of IRES trans-acting factors in carcinogenesis
Faye, M. D., & Holčı́k, M. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.09.012 · Cited by 55 · see citing works
Programmed cell death factor 4 (PDCD4), a novel therapy target for metabolic diseases besides cancer
Lu, K., Chen, Q., Li, M., He, L., Riaz, F., Zhang, T., & Li, D. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.06.016 · Cited by 53 · see citing works
PDCD4 inhibits the malignant phenotype of ovarian cancer cells
Wei, Z., Zhang, X., Wang, X., Gao, F., Zhou, C., Zhu, F., Wang, Q., Gao, Q., Ma, C., Sun, W., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01210.x · Cited by 54 · see citing works
Self-citationZhao, L., Huang, S., Tang, S., Jiang, C., Duan, Y., Beutler, J. A., Henrich, C. J., McMahon, J. B., Schmid, T., Blees, J. S., et al. (2011) · Journal of Natural Products · doi:10.1021/np200603g · Cited by 51 · see citing works
Self-citationHwang, S.-K., Baker, A. R., Young, M. R., & Colburn, N. H. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu008 · Cited by 49 · see citing works
Self-citationSong, X., Zhang, X., Wang, X., Zhu, F., Guo, C. H., Wang, Q., Shi, Y., Wang, J., Chen, Y., & Zhang, L. (2013) · Autophagy · doi:10.4161/auto.24069 · Cited by 49 · see citing works
Self-citationOncogenic miRNAs and target therapies in colorectal cancer
Saberinia, A., Alinezhad, A., Jafari, F., Soltany, S., & Akhavan‐Sigari, R. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.012 · Cited by 49 · see citing works
Guo, Z., Jiang, J., Zhang, J., Yang, H., Yang, F., Qi, Y., Zhong, Y., Su, J. S., Yang, R., Li, L., et al. (2015) · Medicine · doi:10.1097/md.0000000000001806 · Cited by 48 · see citing works
Self-citationMicroarray-Based Cancer Prediction Using Soft Computing Approach
Wang, X., & Gotoh, O. (2009) · Cancer Informatics · doi:10.4137/cin.s2655 · Cited by 47 · see citing works
Zhang, S., Li, J., Jiang, Y., Xu, Y., & Qin, C. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-71 · Cited by 47 · see citing works
Liu, F., Song, D., Wu, Y., Liu, X., Zhu, J., & Tang, Y. (2017) · Thoracic Cancer · doi:10.1111/1759-7714.12492 · Cited by 47 · see citing works
Programmed cell death 4 protein in esophageal cancer
Rugge (2010) · Oncology Reports · doi:10.3892/or_00000838 · Cited by 45 · see citing works
Zhang, N., DUAN, W.-D., Leng, J., Zhou, L., Wang, X., Xu, Y., WANG, X.-D., Zhang, A., & Dong, J. (2015) · Oncology Reports · doi:10.3892/or.2015.3710 · Cited by 44 · see citing works
Ubiquitin-specific protease 4 inhibits breast cancer cell growth through the upregulation of PDCD4
Li, Y., Jiang, D., Zhang, Q., Liu, X., & Cai, Z. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2685 · Cited by 44 · see citing works
RetractedWang, L., Zhao, M., Guo, C. H., Wang, G., Zhu, F., Wang, J., Wang, X., Wang, Q., Zhao, W., Shi, Y., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000729 · Cited by 43 · see citing works
Self-citationFAT1 is a novel upstream regulator of HIF1α and invasion of high grade glioma
Madan, E., Dikshit, B., Gowda, S. H., Srivastava, C., Sarkar, C., Chattopadhyay, P., Sinha, S., & Chosdol, K. (2016) · International Journal of Cancer · doi:10.1002/ijc.30386 · Cited by 42 · see citing works
Li, Y., Wang, X., Wang, X., Wan, L., Liu, Y., Shi, Y., Zhang, L., Fang, Z., & Wei, Z. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy052 · Cited by 42 · see citing works
SNPs in miRNAs and Target Sequences: Role in Cancer and Diabetes
Chhichholiya, Y., Suryan, A. K., Suman, P., Munshi, A., & Singh, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.793523 · Cited by 41 · see citing works
Wang, M., Wang, Y., Zang, W., Wang, H., Chu, H., Li, P., Li, M., Zhang, G., & Zhao, G. (2013) · Tumor Biology · doi:10.1007/s13277-013-1004-8 · Cited by 41 · see citing works
Saxena, A., Shoeb, M., Ramana, K. V., & Srivastava, S. K. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.05.031 · Cited by 41 · see citing works
Wang, Q., Zhang, Y., & Yang, H. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.07.004 · Cited by 41 · see citing works
Self-citationLunardi, D., Abelli, L., Panti, C., Marsili, L., Fossi, M. C., & Mancia, A. (2016) · Marine Environmental Research · doi:10.1016/j.marenvres.2016.01.002 · Cited by 41 · see citing works
Fawzy, M. S., Toraih, E. A., Ibrahiem, A. T., Abdeldayem, H., Mohamed, A. O., & Abdel‐Daim, M. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187310 · Cited by 41 · see citing works
4‐protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
Marchi, T. D., Liu, N. Q., Stingl, C., Timmermans, M. A. M., Smid, M., Look, M. P., Tjoa, M., Braakman, R. B. H., Opdam, M., Linn, S. C., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.07.004 · Cited by 39 · see citing works
Gu, W., Gao, T., Shen, J., Sun, Y., Zheng, X., Ji, W., Ma, J., Hu, X.-Y., Li, J., & Hu, M. (2014) · PubMed Central · Cited by 40 · see citing works
The mechanisms and clinical significance of PDCD4 in colorectal cancer
Long, J., Yin, Y., Guo, H., Li, S., Sun, Y., Zeng, C., & Zhu, W. (2018) · Gene · doi:10.1016/j.gene.2018.09.034 · Cited by 40 · see citing works
Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation
Schmid, T., Bajer, M. M., Blees, J. S., Eifler, L. K., Milke, L., Rübsamen, D., Schulz, K., Weigert, A., Baker, A. R., Colburn, N. H., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr131 · Cited by 39 · see citing works
Self-citationZhang, X., Wang, X., Song, X., Liu, C., Shi, Y., Wang, Y., Afonja, O., Ma, C., Chen, Y. H., & Zhang, L. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01664.x · Cited by 39 · see citing works
Biyanee, A., Ohnheiser, J., Singh, P., & Klempnauer, K.-H. (2015) · Oncogene · doi:10.1038/onc.2014.83 · Cited by 37 · see citing works
Wu, Q., Ma, J., Meng, W., & Hui, P. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1647050 · Cited by 37 · see citing works
The inhibitory action of PDCD4 in lipopolysaccharide/D-galactosamine-induced acute liver injury
Wang, X., Zhang, L., Wei, Z., Zhang, X., Gao, Q., Ma, Y., Liu, X., Jiang, Y. Z., Liu, X., Guo, C., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2012.174 · Cited by 36 · see citing works
- Authors
- Yang, H.-S., Matthews, C. P., Clair, T., Wang, Q., Baker, A. R., Li, C.-C. H., Tan, T.-H., & Colburn, N. H.
- Affiliations
- National Cancer Institute (US)
- Department of Immunology, Bayer College of Medicine, Houston, Texas 77030
- Corresponding author
- Yang, Hsin-Sheng
- Colburn, Nancy H.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2006-02-01
- Volume
- 26
- Issue
- 4
- Pages
- 1297-1306
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC1367180
- OpenAlex
- W2159430811
- Cited by
- 202
- References
- 52
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 2 · 2023: 1 · 2022: 6 · 2021: 9 · 2020: 10 · 2019: 6 · 2018: 8 · 2017: 10 · 2016: 12 · 2015: 12 · 2014: 13 · 2013: 18 · 2012: 14
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- University of Texas MD Anderson Cancer Center
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- PDCD4, MAP4K1, HPK1, JNK activation, c-Jun activation, AP-1 transcription, colon cancer, tumor invasion, metastasis, tumor suppressor, RKO cells
- MeSH terms
- Base Sequence, Cell Movement, Cloning, Molecular, Colonic Neoplasms, DNA, Neoplasm, Enzyme Activation, Extracellular Matrix, Humans, Neoplasm Invasiveness, Phosphorylation, Promoter Regions, Genetic, Transcription, Genetic, Transfection, Down-Regulation, RNA-Binding Proteins, Protein Serine-Threonine Kinases, Transcription Factor AP-1, Oligonucleotide Array Sequence Analysis, MAP Kinase Signaling System, Cell Line, Tumor, JNK Mitogen-Activated Protein Kinases, Apoptosis Regulatory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review